文献速递细菌感染、耐药与抗菌药物

非洲抗菌药物耐药监测系统的系统综述

Systematic review of surveillance systems for AMR in Africa.
PubMed 文献 · J Antimicrob Chemother · 2022-01-01

该综述检索五个电子数据库及灰色文献,评估非洲全球抗菌药物耐药和运用监测系统(GLASS)报告及国家行动计划实施情况。共纳入32条记录,识别41个监测系统(30个国家、11个跨国),最终23个国家系统符合标准;部分系统缺乏外部质量评估,感染来源、患者人群和病原体类型报告有限。

要点

  • 非洲47国中23国实施了抗菌药物耐药监测,但监测方法和报告方案存在局限。
  • 部分国家监测系统缺乏外部质量评估(EQA)。
  • 感染来源、患者人群和病原体类型等参数报告有限。

核心结论

  • 综述显示非洲47国中23国已实施抗菌药物耐药监测,但监测方法和报告方案的多种局限可损害数据的有效性、可靠性和可信度。

研究设计与样本

  • 系统综述,检索PubMed、Scopus、Embase、AJOL和Cochrane五个电子数据库及灰色文献,纳入英文文献,于2020年7月31日在PROSPERO注册(CRD42020192165)。
  • 共发现4304条记录,32条符合初始纳入标准(4篇同行评议文献和28篇灰色文献)。

主要发现

  • 从32条记录中识别41个监测系统(30个国家系统、11个跨国系统)。
  • 最终审查报告结局后,仅23个国家监测系统符合纳入标准。
  • 部分系统缺乏外部质量评估(EQA),感染来源、患者人群和病原体类型等参数报告有限。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Surveillance is a useful tool for tracking antimicrobial resistance (AMR) trends, patterns, therapeutic and policy interventions. Proper correlation of surveillance data gives meaningful insight into the underlying epidemiology and facilitates development of rational interventions. This comprehensive review aims to identify, classify and assess gaps in Global Antimicrobial Resistance and Use Surveillance System (GLASS) reporting and national action plan (NAP) implementation in Africa. METHODS: Articles published in English were searched across five electronic databases (PubMed, Scopus, Embase, AJOL and Cochrane) and grey literature. Articles were screened against inclusion/exclusion criteria and data from eligible studies were retrieved and analysed. This systematic review was registered in the International Prospective Register of Systematic Reviews (PROSPERO) on 31 July 2020 under protocol CRD42020192165. RESULTS: Of the 4304 records found, only 32 met the initial inclusion criteria (4 peer reviews and 28 were grey literature). From these records, 41 surveillance systems were identified (30 national and 11 transnational). After final review of reported outcomes, only 23 national surveillance systems met the inclusion criteria. Indicators recorded from these systems shows lack of external quality assessment (EQA) in some systems and limited reporting of parameters such as infection origin, patient population and pathogen types. CONCLUSIONS: The outcome of the review shows that although AMR surveillance has been implemented in 23 out of the 47 countries in the region, a number of limitations exist in the surveillance methods and reporting protocols that can impair the usefulness, validity and trustworthiness of data generated from these surveillance systems.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Okolie OJ, Igwe U, Ismail SU, et al. Systematic review of surveillance systems for AMR in Africa. J Antimicrob Chemother. 2022. PMID: 36227707. doi:10.1093/jac/dkac342

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。